Merrion H1 profits down despite revenue increase

ISEQ-quoted Merrion Pharmaceuticals today reported a net loss of €2.3m for the six months to end June, compared to a loss of €2.1m for H1 2008.

ISEQ-quoted Merrion Pharmaceuticals today reported a net loss of €2.3m for the six months to end June, compared to a loss of €2.1m for H1 2008.

The decrease came despite a 378% increase in revenues to €1.7m from €354,000 in the same period of the previous year.

You have reached your article limit. Already a subscriber? Sign in

Unlimited access starts here.

Try from only €0.25 a day.

Cancel anytime

More in this section

The Business Hub

Newsletter

News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited